GB1219219A - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
GB1219219A
GB1219219A GB2428569A GB2428569A GB1219219A GB 1219219 A GB1219219 A GB 1219219A GB 2428569 A GB2428569 A GB 2428569A GB 2428569 A GB2428569 A GB 2428569A GB 1219219 A GB1219219 A GB 1219219A
Authority
GB
United Kingdom
Prior art keywords
androstane
pharmaceutical compositions
norandrostane
dioxolane
dioxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2428569A
Inventor
Jean Jacques
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Priority to GB2428569A priority Critical patent/GB1219219A/en
Publication of GB1219219A publication Critical patent/GB1219219A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)

Abstract

1,219,219. A-nor-steroids. MERCK & CO. Inc. 13 May, 1969, No. 24286/69. Addition to 1,169,740. Heading C2C. [Also in Division A5] 2α,16α - Diethynyl - A - nor - androstane - 2#, 16#-diol is prepared from 2-oxo-A-nor-androstane - 17# - ol via 2 - dioxolane - A - norandrostane-17#-ol; the corresponding -17-one; A-nor-androstane-16-oximino-2,17-dione 2-dioxolane; 2,16 - dioxo - A - nor - androstane - 17- ol; 2,16 - dioxo - 17 - tosyloxy - A - norandrostane; 2 - hydroxy - A - nor - androstane- 16-one and A-nor-androstane-2,16-dione.
GB2428569A 1969-05-13 1969-05-13 Pharmaceutical compositions Expired GB1219219A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB2428569A GB1219219A (en) 1969-05-13 1969-05-13 Pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2428569A GB1219219A (en) 1969-05-13 1969-05-13 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
GB1219219A true GB1219219A (en) 1971-01-13

Family

ID=10209299

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2428569A Expired GB1219219A (en) 1969-05-13 1969-05-13 Pharmaceutical compositions

Country Status (1)

Country Link
GB (1) GB1219219A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105434444A (en) * 2014-09-29 2016-03-30 上海奥奇医药科技有限公司 Oral preparation containing A-nor-5 alpha androstane compound

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105434444A (en) * 2014-09-29 2016-03-30 上海奥奇医药科技有限公司 Oral preparation containing A-nor-5 alpha androstane compound
WO2016050193A1 (en) * 2014-09-29 2016-04-07 陈雅君 Oral formulation of a-nor-5α androstane compound
AU2015327509B2 (en) * 2014-09-29 2018-04-26 Yajun Chen Oral formulation of A-nor-5a androstane compound
US10537583B2 (en) 2014-09-29 2020-01-21 Yajun CHEN Oral formulation of A-nor-5α androstane compound
EP3202404B1 (en) * 2014-09-29 2024-03-27 Yajun Chen Oral formulation of a-nor-5alpha androstane compound

Similar Documents

Publication Publication Date Title
GB1333317A (en) Substituted glutaronitriles as antijungal agents
GB1469862A (en) Therapeutic compositions containing etherified monosaccharide derivatives and method of using the same
GB1461062A (en) Oxygenated tricyclic derivatives as perfuming and flavouring agents
GB1219219A (en) Pharmaceutical compositions
GB1301555A (en)
GB1270049A (en) New pharmaceutical product
GB1363404A (en) Epoxides
GB1457144A (en) Cephalosporin derivatives
ES426711A1 (en) 17{62 -hydroxy-16,16-dimethylester-4-en-3-one
GB1435685A (en) Hydroxyl-subst
GB1425409A (en) Radiation-sensitive polymers and their use
GB1333615A (en) Cyclopentane derivatives
GB1449146A (en) Prostaglandins and the preparation thereof
GB1235768A (en) 6,7 - methylene - 20 - spiroxanes
GB1433845A (en) Phar
GB1322766A (en) Tricarbocyanine dyes
GB1252995A (en)
GB1255891A (en) Cyclopentapyrimidine derivative
GB1195943A (en) Novel 17-Valerates of 6,9-Difluoro-Steroids
ES374657A1 (en) Substituted derivatives of 1,1-dichloroalkene-1 and their preparation and uses
GB1270373A (en) 6-chloropregnadienes
GB1463908A (en) 1-dimethylamino-methyl-6-substituted-4h-s-triazolo-4,3-a- 1,4-benzodiazepine
GB1285849A (en) 9alpha-FLUORO-16alpha-METHYL-PREGNANE COMPOUNDS
GB1371693A (en) 4,6-dihydro-1,3-dimethyl-4-ethyl-8-phenylpyrazolo-4,3-e-1,4- diazepin-5-1h-one and compositions containing the same
GB1232093A (en)